Clinical findings in eyes with BEST1-related retinopathy complicated by choroidal neovascularization

Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1125-1137. doi: 10.1007/s00417-021-05447-y. Epub 2021 Oct 18.

Abstract

Purpose: To determine the characteristics of eyes diagnosed with Best vitelliform macular dystrophy (BVMD) and autosomal recessive bestrophinopathy (ARB) complicated by choroidal neovascularization (CNV).

Methods: This was a retrospective, multicenter observational case series. Fourteen genetically confirmed BVMD patients and 9 ARB patients who had been examined in 2 ophthalmological institutions in Japan were studied. The findings in a series of ophthalmic examinations including B-scan optical coherence tomography (OCT) and OCT angiography (OCTA) were reviewed.

Results: CNV was identified in 5 eyes (17.9%) of BVMD patients and in 2 eyes (11.1%) of ARB patients. Three of 5 eyes with BVMD were classified as being at the vitelliruptive stage and 2 eyes at the atrophic stage. The CNV in 2 BVMD eyes were diagnosed as exudative because of acute visual acuity reduction, retinal hemorrhage, and intraretinal fluid, while the CNV in 3 BVMD eyes and 2 ARB eyes were diagnosed as non-exudative. The visual acuity of the two eyes with exudative CNV did not improve despite anti-VEGF treatments. None of the eyes with non-exudative CNV had a reduction of their visual acuity for at least 4 years. All of the CNV were located within hyperreflective materials which were detected in 16 eyes (57.1%) of the BVMD eyes and in 7 eyes (38.9%) of the ARB eyes.

Conclusions: CNV is a relatively common complication in BEST1-related retinopathy in Asian population as well. The prognosis of eyes with exudative CNV is not always good, and OCTA can detect CNV in eyes possessing hyperreflective materials.

Keywords: Autosomal recessive bestrophinopathy; Best vitelliform macular dystrophy; Choroidal neovascularization; Hyperreflective materials; Optical coherence tomography angiography.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Bestrophins* / genetics
  • Choroidal Neovascularization* / diagnosis
  • Choroidal Neovascularization* / drug therapy
  • Choroidal Neovascularization* / etiology
  • Fluorescein Angiography / methods
  • Humans
  • Japan
  • Retinal Diseases* / diagnosis
  • Retrospective Studies
  • Tomography, Optical Coherence / methods
  • Vitelliform Macular Dystrophy* / complications
  • Vitelliform Macular Dystrophy* / diagnosis

Substances

  • BEST1 protein, human
  • Bestrophins